203 related articles for article (PubMed ID: 9062156)
1. Preevacuation serum CA 125 in complete hydatidiform mole.
Tangtrakul S; Srisupandit S; Chailurkit LO; Rajatanavin R
Gynecol Oncol; 1997 Mar; 64(3):487-9. PubMed ID: 9062156
[TBL] [Abstract][Full Text] [Related]
2. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
3. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in complete hydatidiform mole.
Sukcharoen N; Mutirangura A; Limpongsanurak S
J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
7. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
Dawood MY; Saxena BB
Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of zinc and copper in hydatidiform mole.
Harma M; Harma M; Kocyigit A; Keles H
Arch Gynecol Obstet; 2005 Apr; 271(4):304-6. PubMed ID: 15014951
[TBL] [Abstract][Full Text] [Related]
9. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
Obstet Gynecol; 1994 Jan; 83(1):35-42. PubMed ID: 8272304
[TBL] [Abstract][Full Text] [Related]
10. Repetitive complete and partial hydatidiform mole.
Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
[TBL] [Abstract][Full Text] [Related]
11. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
12. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
Boots LR; Hatch KD; Younger JB
Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
[No Abstract] [Full Text] [Related]
13. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
14. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
[TBL] [Abstract][Full Text] [Related]
17. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
18. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
Osathanondh R; Berkowitz RS; de Cholnoky C; Smith BS; Goldstein DP; Tyson JE
J Reprod Med; 1986 Mar; 31(3):179-83. PubMed ID: 3009803
[TBL] [Abstract][Full Text] [Related]
19. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
20. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
